{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T01:47:13Z","timestamp":1778291233119,"version":"3.51.4"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[2001,8,14]]},"DOI":"10.1212\/wnl.57.3.481","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:55:24Z","timestamp":1336917324000},"page":"481-488","source":"Crossref","is-referenced-by-count":397,"title":["A 1-year, placebo-controlled preservation of function survival study of donepezil in AD patients"],"prefix":"10.1212","volume":"57","author":[{"given":"R. C.","family":"Mohs","sequence":"first","affiliation":[{"name":"From the Bronx VA Medical Center (Dr. Mohs), New York, NY; Baylor College of Medicine (Dr. Doody), Houston, TX; Washington University School of Medicine (Dr. Morris), St. Louis, MO; Eisai, Inc. (Drs. Rogers and Pratt and C. Perdomo), Teaneck, NJ."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. S.","family":"Doody","sequence":"additional","affiliation":[{"name":"From the Bronx VA Medical Center (Dr. Mohs), New York, NY; Baylor College of Medicine (Dr. Doody), Houston, TX; Washington University School of Medicine (Dr. Morris), St. Louis, MO; Eisai, Inc. (Drs. Rogers and Pratt and C. Perdomo), Teaneck, NJ."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.C.","family":"Morris","sequence":"additional","affiliation":[{"name":"From the Bronx VA Medical Center (Dr. Mohs), New York, NY; Baylor College of Medicine (Dr. Doody), Houston, TX; Washington University School of Medicine (Dr. Morris), St. Louis, MO; Eisai, Inc. (Drs. Rogers and Pratt and C. Perdomo), Teaneck, NJ."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. R.","family":"Ieni","sequence":"additional","affiliation":[{"name":"From the Bronx VA Medical Center (Dr. Mohs), New York, NY; Baylor College of Medicine (Dr. Doody), Houston, TX; Washington University School of Medicine (Dr. Morris), St. Louis, MO; Eisai, Inc. (Drs. Rogers and Pratt and C. Perdomo), Teaneck, NJ."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S. L.","family":"Rogers","sequence":"additional","affiliation":[{"name":"From the Bronx VA Medical Center (Dr. Mohs), New York, NY; Baylor College of Medicine (Dr. Doody), Houston, TX; Washington University School of Medicine (Dr. Morris), St. Louis, MO; Eisai, Inc. (Drs. Rogers and Pratt and C. Perdomo), Teaneck, NJ."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C. A.","family":"Perdomo","sequence":"additional","affiliation":[{"name":"From the Bronx VA Medical Center (Dr. Mohs), New York, NY; Baylor College of Medicine (Dr. Doody), Houston, TX; Washington University School of Medicine (Dr. Morris), St. Louis, MO; Eisai, Inc. (Drs. Rogers and Pratt and C. Perdomo), Teaneck, NJ."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. D.","family":"Pratt","sequence":"additional","affiliation":[{"name":"From the Bronx VA Medical Center (Dr. Mohs), New York, NY; Baylor College of Medicine (Dr. Doody), Houston, TX; Washington University School of Medicine (Dr. Morris), St. Louis, MO; Eisai, Inc. (Drs. Rogers and Pratt and C. Perdomo), Teaneck, NJ."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"for the \u201c312\u201d Study Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"e_1_3_2_2_2","first-page":"293","volume":"7","year":"1996","unstructured":"Rogers SL, Friedhoff LT, and the Donepezil Study Group. The efficacy and safety of donepezil in patients with Alzheimer\u2019s disease: results of a US multicenter, randomized, double-blind, placebo-controlled trial. Dementia . 1996; 7: 293\u2013303.","journal-title":"Dementia"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.158.9.1021"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.50.1.136"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1159\/000017126"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.54.12.2269"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.v60n0510"},{"key":"e_1_3_2_8_2","first-page":"633","volume":"318","year":"1999","unstructured":"R\u00f6sler M, Anand R, Cicin\u2013Sain A, et al. Efficacy and safety of rivastigmine in patients with Alzheimer\u2019s disease: international randomised controlled trial. Brit Med J . 1999; 318: 633\u2013640.","journal-title":"Brit Med J"},{"key":"e_1_3_2_9_2","unstructured":"American Psychiatric Association (APA).  Diagnostic and statistical manual of mental disorders 4th ed.   Washington DC:   APA 1994."},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.34.7.939"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002093-199809000-00005"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/geront\/9.3_Part_1.179"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002093-199700112-00005"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410310303"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.43.11.2412-a"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.114.511.787"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.48.6.1508"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(75)90026-6"},{"key":"e_1_3_2_19_2","first-page":"A470.","volume":"54","year":"2000","unstructured":"Waldemar G, Winblad B, Engedal K, et al. Donepezil benefits patients with either mild or moderate Alzheimer\u2019s disease over one year. Neurology . 2000; 54 (suppl 3): A470.Abstract.","journal-title":"Neurology"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0924-977X(00)00067-5"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.58.3.427"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1159\/000008243"},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.54.12.2261"},{"key":"e_1_3_2_24_2","unstructured":"Sobel   JD Kay   D.   Urinary tract infections. In:  Mandell  GL Douglas  GL Douglas  RG Jr Bennett  JE eds.  Principles and practice of infectious diseases 3rd ed.   New York:   Churchill Livingstone 1990:  582\u2013611."}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.57.3.481","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T16:59:58Z","timestamp":1711645198000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.57.3.481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,8,14]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,8,14]]}},"alternative-id":["10.1212\/WNL.57.3.481"],"URL":"https:\/\/doi.org\/10.1212\/wnl.57.3.481","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,8,14]]}}}